Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Watson Pharmaceuticals

Founders Allen Chao David Hsia


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
The average size of a deal this fund participated in
Portfolio companies 1
Rounds per year 0.03
Lead investments 1
Key employees Soon

Areas of investment

  • Pharmaceutical
  • Biotechnology
  • Medical Device

Watson Pharmaceuticals is the famous Corporate Investor, which was founded in 1983. The company was established in North America in United States. The leading representative office of defined Corporate Investor is situated in the Corona.

The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2010.

Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Biotechnology. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline moksha8 Pharmaceuticals

The typical case for the fund is to invest in rounds with 1 participant. Despite the Watson Pharmaceuticals, startups are often financed by TPG Biotech, Montreux Equity Partners. In the next rounds fund is usually obtained by Forest Laboratories.

The fund was created by Allen Chao, David Hsia.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Arete Corporation Center Harbor, New Hampshire, United States
Banque de Vizille France, Lyon, Rhone-Alpes
Cambridge Capital Florida, United States, West Palm Beach
Carat England, London, United Kingdom
Eudaimonia Capital Central Region, Singapore, Singapore
Everbright Securities China, Shanghai
Evolem Start France, Lyon, Rhone-Alpes
Gemcorp England, London, United Kingdom
Goodgrower Community of Madrid, Madrid, Spain
Highlander Partners Dallas, Texas, United States
iStart -
Japan Tobacco Japan, Tokyo
Jiayoubao China, Guangdong, Shenzhen
NewWorld Capital Group LLC New York, New York, United States
PROTO Japan Aichi Prefecture, Japan, Nagoya
PT. United Family Food Indonesia, Jakarta, Jakarta Raya
Sandalphon Capital Chicago, Illinois, United States
Tennenbaum Capital Partners California, Santa Monica, United States
Umpqua Bank Oregon, Roseburg, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

moksha8 Pharmaceuticals

Medical Device
$30M05 Oct 2010 Radnor Township, Pennsylvania, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Watson Pharmaceuticals?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: